Rhythm Pharmaceuticals, Inc.
RYTM
$59.93
-$0.25-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.39% | -41.11% | -39.56% | -42.36% | -51.70% |
| Total Depreciation and Amortization | -9.67% | -11.09% | -10.43% | -7.23% | -4.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.95% | 220.78% | 175.49% | 243.75% | 319.61% |
| Change in Net Operating Assets | 3,695.56% | 119.99% | 587.18% | 120.24% | 98.48% |
| Cash from Operations | 19.21% | 16.36% | 11.62% | 18.96% | 10.09% |
| Capital Expenditure | -- | -- | 102.13% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,002.06% | -757.48% | 32.36% | -271.69% | 122.92% |
| Cash from Investing | -1,002.06% | -750.36% | 32.41% | -267.89% | 122.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 36.83% | -1.75% | -73.42% | -54.95% | -55.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -137.53% | -123.57% | -116.38% | -29.23% | -78.11% |
| Cash from Financing | 178.75% | 157.16% | 73.93% | 29.20% | -63.08% |
| Foreign Exchange rate Adjustments | 123.75% | 101.41% | -2,434.00% | -1,703.70% | -447.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 193.89% | 143.19% | 85.94% | 1,761.77% | -280.25% |